Dentsply International | XRAY - Ebitda

Stock Price
10.07
Daily Change
-0.34 -3.27%
Monthly
-16.71%
Yearly
-39.70%
Q2 Forecast
9.87

Dentsply International reported $129M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
3M USD 1.42B 8M Mar/2026
Agilent USD 540M 74M Sep/2025
Align Technology USD 260.87M 77.03M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Illumina USD 469M 137M Dec/2025
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Repligen USD 40.01M 469K Mar/2026
Revvity USD 272.91M 24M Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025
Zoetis USD 939M 101M Dec/2025